The lower limits of dexamethasone window in Chinese depressives

Biological Psychiatry

Volumn 44, Issue 7, 1998, Pages 648-655

  Shiah, I Shin ^a   Ko, Huei Chen ^b   Lu, Ru Band ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cortisol; Depression; Dexamethasone; Dexamethasone suppression test; Dexamethasone window; Ethnicity; Pharmacokinetics

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG RESPONSE; ETHNOLOGY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CHINA; DEPRESSIVE DISORDER; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY;

EID: 18744434066     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00549-0     Document Type: Article

References (44)

1. Arana GW, Workman RJ, Baldessarini RJ (1984): Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. Am J Psychiatry 141:1619-1620.
2. Avery DH, Osgood TB, Ishiki DM, Wilson LG, Kenny M, Dunner DL (1985): The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. Am J Psychiatry 142:844-848.
3. Baumgartner A, Haack D, Vecsei P (1986): Series dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables. Psychiatry Res 18:45-64.
4. Berger M, Prike KM, Doerr P, Krieg JC, von Zerssen D (1984): The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 145: 372-382.
5. Berger M, Prike KM, Krieg JC, von Zerssen D (1985): The effect of weight loss and inappropriate plasma dexamethasone levels on the DST. Psychiatry Res 15:351-360.
6. Cameron OG, Kerber K, Curtis GC (1986): Obsessive-compulsive disorder and the DST. Psychiatry Res 19:329-330.
7. Carr V, Morris H, Gilliland L (1986): The effect of serum dexamethasone concentrations in the dexamethasone suppression test. Biol Psychiatry 21:735-743.
8. Carroll BJ, Feinberg M, Greden JF, Haskett RF, James NM, Steiner M, et al (1980): Diagnosis of endogenous depression: Comparison of clinical, research and neuroendocrine criteria. J Affect Disord 2:177-194.
9. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, et al (1981): A specific laboratory test for the diagnosis of melancholia-standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15-22.
10. Catapano F, Monteleone P, Maj M, Kemali D (1990): Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology 23:53-56.
11. Cottreaux JA, Bouvard M, Claustrat B, Juenet C (1984): Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: A confirmatory report. Psychiatry Res 13:157-165.
12. Curtis GC, Cameron OG, Nesse RM (1982): The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry 139:1043-1046.
13. Endicott J, Spitzer RL (1978): A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844.
14. Guthrie S (1991): The impact of dexamethasone pharmacokinetics on the DST: A review. Psychopharmacol Bull 27:565-576.
15. Guthrie SK, Heidt M, Pande A, Grunhaus L, Haskett RF, Hariharan M (1992): A longitudinal evaluation of dexamethasone pharmacokinetics in depressed patients and normal controls. J Clin Psychopharmacol 12:191-196.
16. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
17. Holsboer F (1989): Psychiatric implications of altered limbichypothalamic-pituitary adrenocortical activity. Eur Arch Psychiatry Neurol Sci 238:302-322.
18. Holsboer F, Haack D, Gerken A, Vecoei P (1984): Plasma dexamethasone concentrations and different suppression response of cortisol corticosterone in depressives and controls. Biol Psychiatry 19:181-191.
19. Holsboer F, Wiedemann K, Gerken A, Boll E (1986): The plasma dexamethasone variable in depression: Test-retest studies and early biophase kinetics. Psychiatry Res 17:97-103.
20. Hunt GE, Johnson GF, Caterson ID (1989): The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls. J Affect Disord 17:21-32.
21. Hunt GE, O'Sullivan BT, Johnson GF, Caterson ID (1991): Effect of high plasma dexamethasone levels on DST sensitivity: Dose-response study in depressed patients and controls. Psychiatry Res 36:209-222.
22. Hwu HG, Lin HN (1990): Serial dexamethasone suppression test in psychiatric inpatients. Biol Psychiatry 27:609-616.
23. Hwu HG, Lin HN, Lu RB (1987): Dexamethasone suppression test in psychiatric diagnosis and psychophathology for Chinese patients. Proc Natl Sci Counc Repub China A 11:164-174.
24. Insel TR, Kalin NH, Guttmacher LB, Cohen RM, Murphy DL (1982): The dexamethasone suppression test in patients with primary obsessive-compulsive disorder. Psychiatry Res 6:153-160.
25. Jenike MA, Baer L, Brotman AW, Goff DC, Minichiello WE, Regan NJ (1987): Obsessive-compulsive disorder, depression, and the dexamethasone suppression test. J Clin Psychopharmacol 7:182-184.
26. Johnson GF, Hunt G, Kerr K, Caterson I (1984): Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients. Psychiatry Res 13:305-313.
27. Johnson GF, Hunt G, Kerr K, Caterson I (1986): Plasma dexamethasone concentrations and the dexamethasone suppression test. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpon GM, editors. Proceedings of the IVth World Congress of Biological Psychiatry, Philadelphia. New York: Elsevier, pp 811-816.
28. Johnson GF, Hunt G, Kerr K, Caterson I (1987): The plasma dexamethasone "window" and the dexamethasone suppression test in depression. Biol Psychiatry 22:1035-1039.
29. Khan A, Johnson F, Avery DH, Cohen S, Scherzo B, Dunner DL (1988): DST results in nonpsychotic depressed outpatients. Am J Psychiatry 145:1153-1156.
30. Lieberman JA, Brenner R, Lesser M, Coccaro E, Borenstein M, Kane JM (1983): Dexamethasone suppression tests in patients with panic disorder. Am J Psychiatry 140:917-919.
31. Lieberman JA, Kane JM, Sarantakos S, Cole K, Howard A, Borenstein M, et al (1985): Dexamethasone suppression tests in patients with obsessive-compulsive disorder. Am J Psychiatry 142:747-751.
32. Lin KM, Poland RE, Silver B (1993): Overview: The interface between psychobiology and ethnicity. In: Lin KM, Poland RE, Nakasaki G, editors. Psychopharmacology and Psychobiology of Ethnicity. Washington, DC: American Psychiatric Press, pp 11-35.
33. Lin KM, Anderson D, Poland RE (1995): Ethnicity and psychopharmacology. Bridging the gap. Psychiatr Clin North Am 18:635-647.
34. Lu RB, Ho SL, Ho BT, Leu SY, Shian LR, Chen WL (1986): Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone non-suppressors. J Affect Disord 10:177-184.
35. Lu RB, Ho SL, Huang HC, Lin YT (1988): The specificity of the dexamethasone suppression test in endogenous depressive patients. Neuropsychopharmacology 1:157-162.
36. Maguire KP, Schweitzer IBN, Bridge S, Tiller JW (1987): The dexamethasone suppression test: Importance of dexamethasone concentrations. Biol Psychiatry 22:957-967.
37. Meikle AW (1982): Dexamethasone suppression tests: Usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol 16:401-408.
38. Morris H, Carr V, Gilliard J, Hopper M (1986): Dexamethasone concentrations and the DST in psychiatric disorders. Br J Psychiatry 148:66-69.
39. O'Sullivan BT, Hunt GE, Johnson GF, Caterson ID (1989): The plasma dexamethasone window: Evidence supporting its usefulness to validate dexamethasone suppression test results. Biol Psychiatry 25:739-754.
40. Poland RE, Rubin RT, Lane LA, Hart PJ, Lesser IM (1987): Serum dexamethasone concentration and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response. Arch Gen Psychiatry 44:790-795.
41. Poland RE, Rubin RT, Lesser IM (1988): Serum dexamethasone concentration in endogenous depressives before, during and after treatment: Preliminary observations. Biol Psychiatry 23:705-710.
42. Ritchie JC, Belkin BM, Krishnan KR, Nemeroff CB, Carroll BJ (1990): Plasma dexamethasone concentrations and the dexamethasone suppression test. Biol Psychiatry 27:159-173.
43. Rubin RT, Poland RE, Blodgett ALN, Winston RA, Forster B, Carroll BJ (1980): Cortisol dynamics dexamethasone pharmacokinetics in primary ED: Preliminary finding. In: Bramillilla F, Racagni G, de Weids D, editors. Progress in Psychoneuroendocrinology. Amsterdam: Elsevier/North Holland, pp 223-234.
44. von Bardeleben U, Holsboer F, Stalla GK, Muller OA (1985): Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci 37:1613-1618.